NCT01207687 2018-08-27Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)National Cancer Institute (NCI)Phase 2 Completed14 enrolled 28 charts
NCT01119599 2015-09-29RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaNational Cancer Institute (NCI)Phase 1 Completed22 enrolled